Study of CGC-11047 in Patients With Metastatic Hormone Refractory Prostate Cancer
This study has been terminated.
(Further evaluation of phase I dosing)
Sponsor:
University of Wisconsin, Madison
Collaborator:
Progen Pharmaceuticals
Information provided by:
University of Wisconsin, Madison
ClinicalTrials.gov Identifier:
NCT00585416
First received: December 21, 2007
Last updated: April 13, 2009
Last verified: April 2009
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been terminated. |
|---|---|
| Study Completion Date: | March 2009 |
| Primary Completion Date: | November 2007 (Final data collection date for primary outcome measure) |